Advanced Biomedical Technologies Stock Net Income
| ABMT Stock | USD 0.0004 0.0002 100.00% |
Advanced Biomedical's fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting Advanced Pink Sheet price.
Advanced |
Advanced Biomedical Technologies Company Net Income Analysis
Advanced Biomedical's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Advanced Biomedical Net Income | (672 K) |
Most of Advanced Biomedical's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Advanced Biomedical Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Advanced Biomedical Technologies reported net income of (672,000). This is 100.2% lower than that of the Health Care Equipment & Supplies sector and 100.28% lower than that of the Health Care industry. The net income for all United States stocks is 100.12% higher than that of the company.
Advanced Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Advanced Biomedical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Advanced Biomedical could also be used in its relative valuation, which is a method of valuing Advanced Biomedical by comparing valuation metrics of similar companies.Advanced Biomedical is currently under evaluation in net income category among its peers.
Advanced Fundamentals
| Return On Asset | -0.78 | |||
| Operating Margin | (3.86) % | |||
| Current Valuation | 3.52 M | |||
| Shares Outstanding | 70.22 M | |||
| Shares Owned By Insiders | 3.32 % | |||
| Price To Earning | (12.00) X | |||
| Price To Sales | 31.97 X | |||
| Revenue | 123.59 K | |||
| Gross Profit | 71.77 K | |||
| EBITDA | (282.69 K) | |||
| Net Income | (672 K) | |||
| Cash And Equivalents | 6.98 K | |||
| Total Debt | 6.36 M | |||
| Debt To Equity | (1.04) % | |||
| Current Ratio | 0.03 X | |||
| Book Value Per Share | (0.12) X | |||
| Cash Flow From Operations | 646.66 K | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 17 | |||
| Beta | 0.63 | |||
| Market Capitalization | 4.14 M | |||
| Total Asset | 469.23 K | |||
| Retained Earnings | (2.88 M) | |||
| Working Capital | (4.38 M) | |||
| Current Asset | 34 K | |||
| Current Liabilities | 4.42 M | |||
| Z Score | -19.2 | |||
| Net Asset | 469.23 K |
About Advanced Biomedical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Advanced Biomedical Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Advanced Biomedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Advanced Biomedical Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Advanced Pink Sheet Analysis
When running Advanced Biomedical's price analysis, check to measure Advanced Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Advanced Biomedical is operating at the current time. Most of Advanced Biomedical's value examination focuses on studying past and present price action to predict the probability of Advanced Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Advanced Biomedical's price. Additionally, you may evaluate how the addition of Advanced Biomedical to your portfolios can decrease your overall portfolio volatility.